More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Exercise, whether moderate- or high-intensity, can help ease Parkinson's symptoms, including fatigue, new research shows. As ...

Moderate- or high-intensity exercise can help with Parkinson's disease symptoms like fatigue, a recent study shows.

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...

According to a study, a class of diabetes medications may be linked to a decreased risk of dementia and Parkinson’s disease. The findings were published in the online edition of Neurology, the medical ...

A blossoming partnership between Cleveland Clinic and a UK-based digital health startup could help Parkinson’s disease ...

The masterclass attracted over 200 delegates and showcased the holistic care model at King’s Dubai Parkinson’s Centre of ...

Teams are taking part in a two-wheeled trek across southwestern Ontario to raise awareness about the benefits of exercise for ...